Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) AI-Powered Stock Analysis
See how Aurobindo Pharma Limited scores across key metrics like financial growth, valuation, and market position on the NSE, using AI-driven evaluation.
AUROPHARMA.NS●NSE
HealthcareDrug Manufacturers - Specialty & Generic
₹1545.70
₹13.70(0.89%)
Indian Market is Open · 12:47
Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) AI-Powered Stock Analysis
See how Aurobindo Pharma Limited scores across key metrics like financial growth, valuation, and market position on the NSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerAurobindo Pharma Limited (NSE: AUROPHARMA.NS) Stock Overall Grade
Aurobindo Pharma Limited's grade for its NSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Aurobindo Pharma Limited's overall NSE stock rating.
Forecast
A+Score
100/100Financial Growth
CScore
40/100Fundamental Growth
B+Score
70/100Key Ratios
BScore
67/100Sector Comparison
BScore
65/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) AI-Powered Stock Analysis
On the NSE, AUROPHARMA.NS demonstrates Good performance with an overall Forecast Score of 100/100 (A+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (70/100, B+) highlight its stability, while Key Ratios (67/100, B) and Sector Comparison (65/100, B) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the NSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests Moderate divergence in outlook.(NSE: AUROPHARMA.NS) Component Analysis Explained
Understand the key factors behind each Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) stock grade, including financials, comparisons, and forecasts.